Medical Devices UK

UK Syndromic Testing Panels Market Analysis, 2024–2034

UK Syndromic Testing Panels Market Industry Trends and Forecast to 2034: Segmented by (Panel, Technology, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

UK · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $65.6 Mn Estimated value
Estimate 2025 $69.4 Mn 2.3% of the global market
Projected 2034 $116.3 Mn 67.5% Adds $46.9 Mn over 9 forecast years
CAGR 2025–2034 5.9% Faster than 42% of 173 Medical Devices markets here
Key players 5
  • UK is 2.29% of the global market.
  • In Europe, the largest is Germany at $95.0 Mn.
  • Fastest growing: Russia at 8% a year.
  • UK ranks 3rd of 6 by size in Europe.

Market size projection

UK

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$46.9 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Syndromic Testing Panels Market market size by year, UK
YearMarket sizeChange that yearSince 2025
2024 (estimate) $65.6 Mn — —
2025 (base) $69.4 Mn +$3.9 Mn —
2026 (forecast) $73.5 Mn +$4.1 Mn +5.9%
2027 (forecast) $77.9 Mn +$4.3 Mn +12.1%
2028 (forecast) $82.4 Mn +$4.6 Mn +18.8%
2029 (forecast) $87.3 Mn +$4.9 Mn +25.8%
2030 (forecast) $92.5 Mn +$5.2 Mn +33.2%
2031 (forecast) $97.9 Mn +$5.5 Mn +41.1%
2032 (forecast) $103.7 Mn +$5.8 Mn +49.4%
2033 (forecast) $109.8 Mn +$6.1 Mn +58.2%
2034 (forecast) $116.3 Mn +$6.5 Mn +67.5%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $3.03 Bn
  2. North America $1.29 Bn
  3. US $1.24 Bn
  4. APAC $666.2 Mn
  5. Europe $623.2 Mn
  6. Canada $242.8 Mn
  7. China $241.9 Mn
  8. Japan $188.7 Mn
  9. Latin America $155.9 Mn
  10. Middle East $130.7 Mn
  11. Germany $95.0 Mn
  12. Brazil $80.8 Mn
  13. France $75.0 Mn
  14. UK (this report) $69.4 Mn
  15. Italy $62.1 Mn
  16. Spain $57.8 Mn
  17. Ecuador $56.9 Mn
  18. Saudi Arabia $54.5 Mn
  19. Mexico $52.4 Mn
  20. India $51.6 Mn
  21. Africa $49.8 Mn
  22. Australia $37.7 Mn
  23. Russia $34.1 Mn
  24. New Zealand $26.0 Mn
  25. South Africa $20.4 Mn
  26. UAE $16.2 Mn
  27. Egypt $8.8 Mn
  28. Philippines $6.9 Mn
  29. Hong Kong $5.1 Mn
  30. Malaysia $4.8 Mn
  31. Thailand $4.0 Mn
  32. Singapore $3.7 Mn
  33. Kenya $2.3 Mn

The UK Syndromic Testing Panels Market Analysis Executive Summary

Syndromic testing panels check one sample for many possible germs at once, such as all common causes of a chest or gut infection.

Key segments of the syndromic Testing Panels market include panel (Respiratory, Gastrointestinal and Blood Culture) and technology (Multiplex PCR and Microarray).

UK Syndromic Testing Panels Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the syndromic Testing Panels market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the syndromic Testing Panels market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the syndromic Testing Panels market.

Competitive Landscape for Syndromic Testing Panels Market in UK

The syndromic Testing Panels market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Syndromic Testing Panels Market in UK

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how syndromic Testing Panels products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in UK.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Syndromic Testing Panels right now, from free public sources.

Latest research 9 papers since 2021 (worldwide)

  1. Syndromic Testing in Clinical Microbiology and Infectious Diseases: An Updated Review of Diagnostic Performance, Clinical and Healthcare Impact, and Emerging Developments. Microorganisms, 2026
  2. Diagnostic stewardship perceptions and practices among microbiology laboratories: a national survey from the American Society for Microbiology. Journal of clinical microbiology, 2026
  3. Faster Results, Better Care? Impact of Meningitis/Encephalitis Syndromic Panel Testing on Pathogen Detection and Hospital Outcomes Beyond CSF Culture: A Literature Search for Diagnosticians. Diagnostics (Basel, Switzerland), 2026
  4. Integrating Syndromic Molecular Assays into Routine Diagnostic Microbiology: Benefits and Challenges. Antibiotics (Basel, Switzerland), 2026
  5. Rapid testing with molecular syndromic panels of patients presenting at the emergency department with pneumonia at risk for multidrug-resistant pathogens. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2025
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Syndromic Testing Panels in context

The UK compared

  • Health spending per person: 5,860 US$ per person (2024). World: 1,317 US$ per person (2023). 2nd highest of the 6 countries we cover in Europe.[1]
  • Doctors: 3.30 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 5th highest of the 6 countries we cover in Europe.[2]
  • People aged 65 and over: 19.7% of people (2025). World: 10.4% of people (2025). 5th highest of the 6 countries we cover in Europe.[3]

Questions, answered with public data

How much research is published on Syndromic Testing Panels?
PubMed lists 9 papers added since January 2021 that match this market, worldwide.[4]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 13 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.

[4] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Syndromic Testing Panels in UK? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Dermatology Diagnostics: AI and Skin HealthSkin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions… Molecular Point-of-Care Tests: Lab Accuracy, Clinic SpeedTB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade… Healthcare In-Vitro Diagnostics: What Comes After COVIDCOVID-19 testing created a huge, short-lived spike. Long-term demand for in-vitro diagnostics now comes from…
Back to Catalogue
Keep exploring

Related Medical Devices reports in UK

See all
Same topic, other categories

Related on diagnostics and lab testing and infectious diseases

See the topic